YOUR SEARCH FOR Text 109 RESULTS
41 of Total
Incyte Involved | Supporting Our Communities | Incyte.com
… Giving Foundation provides charitable donations to publicly funded 501(c) (3) … Charitable Giving Foundation only provides donations to publicly funded organizations in …
42 of Total
Culture & Careers | Incyte.com
… to patients faster, and the work that we do in drug development plays a significant role … pushing the envelope as far as innovation, doing science that hasn’t been done before…It’s …
43 of Total
Incyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance
… for new atopic dermatitis patients and the adoption in vitiligo has been strong,” said Hervé … cancer (SCAC): Phase 3 (POD1UM-303) MSI-high endometrial cancer: Phase 2 (POD1UM-101, …
44 of Total
0000879169-25-000115 | 8-K | Incyte
… Reports SEC Filings SEC Filing Details Document Details Form 8-K Filing Date Oct 28, 2025 Document Date Oct 28, 2025 Form Description …
45 of Total
Headquarters - Pharmaceutical Research & Development | Incyte.com
… Incyte Biosciences International Sàrl Rue Docteur-Yersin 12 1110 Morges, Switzerland +41 … (0) 21 581 50 00 View Map AUSTRIA DC Tower 1, Donau-City-Straße 7 1220 Vienna Austria +43 1 35 …
46 of Total
Serving Patients Through Innovation | Incyte Stories
… serving patients is what drives everything we do, and we are proud to be a global organization … in mind, we opened the Incyte BioPlant in Yverdon-les-Bains, Switzerland, which enables us to …
47 of Total
Understanding Hidradenitis Suppurativa (HS) | Incyte Stories
… and to keep us healthy. However, sometimes it doesn't function properly and can mistakenly … Kirby: Treatment approaches are tailored by a doctor based on each person's HS, other medical …
48 of Total
Reflections on Living with Vitiligo | Incyte Stories
… yourself – what is your occupation and how do you enjoy spending your free time? Sarah: I'm … an educator. Outside of work, I love being outdoors – hiking, exploring and just being in …
49 of Total
0001104659-25-096632 | 8-K | Incyte
… Reports SEC Filings SEC Filing Details Document Details Form 8-K Filing Date Oct 3, 2025 Document Date Sep 30, 2025 Form Description …
50 of Total
0001558370-22-006808 | 10-Q | Incyte
… Reports SEC Filings SEC Filing Details Document Details Form 10-Q Filing Date May 3, 2022 Document Date Mar 31, 2022 Form Description …